Evolving Risks and Ethical Dilemmas of the Opioid Crisis and Updates in Prescribing Controlled Substances

Instructions

Monday, March 10, 2025, 4:00 PM - Wednesday, March 10, 2027, 11:59 PM


AMA PRA Category 1 Credits™ (2.00 hours), DEA Medication Access and Training Expansion (MATE) Hours (2.00 hours), Tennessee Controlled Substance Prescribing Hours (2.00 hours)

This education is designed to cover the complexities of opioid safety, ethical considerations in prescribing, and evolving regulations. Learners will gain insights into risk mitigation strategies, DEA prescribing updates, and ethical challenges of managing opioid therapy. Designed to support informed, patient-centered decision-making, this education will equip learners with the knowledge and competence to navigate controlled substance prescribing responsibly.

1. Summarize the data on opioid safety focused reductions in opioid prescribing.
2. Describe the roles of payors, health systems, and government in rigid implementation of opioid metrics and their impact on patient care.
3. Discuss recent evidence of forced opioid discontinuations.
4. Discuss ethics and implications of nonconsensual opioid tapers/discontinuations.
5. Identify and incorporate risk mitigation strategies for controlled substances.
6. Recognize DEA rules for telemedicine prescribing of controlled substances.

Ascension Saint Thomas is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Ascension Saint Thomas designates this internet enduring material for a maximum of 2.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in this activity. 

This activity is designed to offer 2 hours of continuing education applicable to the 8-hour DEA Medication Access and Training Expansion (MATE) Act requirements, and will meet the Tennessee Department of Health’s licensure renewal requirements for 2.0 hours of continuing education in controlled substance prescribing, including chronic pain guidelines.

Mitigation of Relevant Financial Relationships

Ascension Saint Thomas is committed to providing CME that is balanced, objective, and evidence-based. In accordance with the Accreditation Council for Continuing Medical Education Standards for Integrity and Independence in Accredited Continuing Education, all individuals who have the opportunity to control content are required to disclose any financial relationships within the past 24 months with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Ascension Saint Thomas has established mechanisms to mitigate relevant financial relationships.

For this activity, the planners and faculty have no relevant financial relationships with ineligible companies.